Caprock Group’s Dentsply Sirona XRAY Stock Holding History

Caprock Group’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-60,387	Closed	-$864K	–	1306
2025 Q3	$864K	Buy	+60,387	New	+$876K	0.02%	621

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Caprock Group's XRAY Position: Q4 2025 in Review

Caprock Group sold out of Dentsply Sirona (XRAY) in Q4 2025, closing a stake of 60,387 shares — an estimated $864K sold.

Caprock Group first reported a position in XRAY in Q3 2025 and held it in 1 quarter. The position peaked at $864K in Q3 2025. 362 funds tracked by Wall St. Rank hold XRAY as of Q4 2025.

Caprock Group reported no remaining Dentsply Sirona position as of Q4 2025 after selling out during the quarter.
Caprock Group sold 60,387 Dentsply Sirona shares in Q4 2025, an estimated $864K.
Caprock Group first reported a position in Dentsply Sirona in Q3 2025 and held it in 1 quarter.
Caprock Group's Dentsply Sirona position peaked at $864K in Q3 2025.
362 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2025.

Based on Caprock Group's 13F filing for Q4 2025, filed 28 Jan 2026.